Market Cap 2.14B
Revenue (ttm) 1.90B
Net Income (ttm) 235.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 12.37%
Debt to Equity Ratio 0.84
Volume 3,730,400
Avg Vol 6,674,762
Day's Range N/A - N/A
Shares Out 97.71M
Stochastic %K 64%
Beta 0.51
Analysts Sell
Price Target $24.57

Company Profile

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dy...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 274 4000
Address:
215 First Street, Suite 415, Cambridge, United States
obryanjfg
obryanjfg Oct. 25 at 12:07 PM
$SRPT Goor try, but that Fierce Bio article (and the stated Elevdys rev) is from Q3 2024. Yes 2024. Try again!
0 · Reply
blueb22
blueb22 Oct. 25 at 11:47 AM
$SRPT - and screen of main part on Elevidys in this article...
0 · Reply
blueb22
blueb22 Oct. 25 at 11:45 AM
$SRPT - this is interesting and very good (didn't see this in normal Google search on Sarepta's news). This suggests US sales will be a huge upward surprise!!! https://www.fiercepharma.com/pharma/roche-sees-no-material-impact-eylea-biosim-surprise-elevidys-dmd-gene-therapy-beat?itm_source=parsely-api
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 10:35 AM
Enter: $SRPT Calls Strike Price: $23 Expiry Date: NOV 14 2025 Buy in Price: $1.84 - $3.10 Sell Price: $3.00 Profit : +63% (Turn every $1 into $1.63) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
tedevan
tedevan Oct. 25 at 8:04 AM
$SRPT anyway to gauge if they big $15 puts were being sold ?
0 · Reply
Lost_My_Shadow
Lost_My_Shadow Oct. 25 at 2:46 AM
$SRPT Family is some of the worst culprits of abandoning and milking. Lend $10 k to any one of your family members and count the days till that relationship blows up. Borrow 10 k from anyone of them and same will happen
0 · Reply
Bezhadimmu
Bezhadimmu Oct. 25 at 2:42 AM
$SRPT go jays! Fuck the dodgers! Their team a bunch of over paid zero chemistry bums! Jays are organically built!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 2:23 AM
Enter: $SRPT NOV 14 2025 $24 CALLS Buy in Price: $1.60 - $2.85 Take Profit: $3.68 Stop Bleeding: $1.41 ROI Potential: 130% https://moneygroup.us/
0 · Reply
conloco
conloco Oct. 25 at 1:51 AM
$SRPT Can’t wait for earnings for Doug to preach what’s been going behind the scenes. All signs point to a great quarter. The weird timing of events and possible buyout talks have surely caused a long overdue PR. Maybe it’s the best course and all of it will make sense in the coming weeks. Nonetheless, not trading this. Just sitting on my position and excited for what’s to come
0 · Reply
Bezhadimmu
Bezhadimmu Oct. 25 at 1:24 AM
$SRPT we have no proof of buyout but can you please provide proof there will not be a buyout. Thank you. Waiting.
3 · Reply
Latest News on SRPT
What's Going On Sarepta Stock On Wednesday?

Oct 8, 2025, 11:19 AM EDT - 16 days ago

What's Going On Sarepta Stock On Wednesday?


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL ILMN IONS MRNA


Sarepta Therapeutics: A Strong Opportunity Amidst The Panic

Aug 22, 2025, 12:12 PM EDT - 2 months ago

Sarepta Therapeutics: A Strong Opportunity Amidst The Panic


Opinion | On Sarepta, a Welcome FDA Reversal

Jul 29, 2025, 5:48 PM EDT - 3 months ago

Opinion | On Sarepta, a Welcome FDA Reversal


SRPT Rallies on FDA Green Light: A New Bottom for the Stock?

Jul 29, 2025, 2:06 PM EDT - 3 months ago

SRPT Rallies on FDA Green Light: A New Bottom for the Stock?


Sarepta: SRPT Stock To $40?

Jul 29, 2025, 9:00 AM EDT - 3 months ago

Sarepta: SRPT Stock To $40?


Sarepta Stock Just Soared 45%. Here's Why.

Jul 29, 2025, 5:01 AM EDT - 3 months ago

Sarepta Stock Just Soared 45%. Here's Why.


Sarepta Therapeutics: Beaten Down, But Not Out

Jul 28, 2025, 4:17 AM EDT - 3 months ago

Sarepta Therapeutics: Beaten Down, But Not Out


Opinion | The Sarepta Mugging and Drug Innovation

Jul 27, 2025, 1:37 PM EDT - 3 months ago

Opinion | The Sarepta Mugging and Drug Innovation


Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS

Jul 25, 2025, 7:51 PM EDT - 3 months ago

Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS


obryanjfg
obryanjfg Oct. 25 at 12:07 PM
$SRPT Goor try, but that Fierce Bio article (and the stated Elevdys rev) is from Q3 2024. Yes 2024. Try again!
0 · Reply
blueb22
blueb22 Oct. 25 at 11:47 AM
$SRPT - and screen of main part on Elevidys in this article...
0 · Reply
blueb22
blueb22 Oct. 25 at 11:45 AM
$SRPT - this is interesting and very good (didn't see this in normal Google search on Sarepta's news). This suggests US sales will be a huge upward surprise!!! https://www.fiercepharma.com/pharma/roche-sees-no-material-impact-eylea-biosim-surprise-elevidys-dmd-gene-therapy-beat?itm_source=parsely-api
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 10:35 AM
Enter: $SRPT Calls Strike Price: $23 Expiry Date: NOV 14 2025 Buy in Price: $1.84 - $3.10 Sell Price: $3.00 Profit : +63% (Turn every $1 into $1.63) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
tedevan
tedevan Oct. 25 at 8:04 AM
$SRPT anyway to gauge if they big $15 puts were being sold ?
0 · Reply
Lost_My_Shadow
Lost_My_Shadow Oct. 25 at 2:46 AM
$SRPT Family is some of the worst culprits of abandoning and milking. Lend $10 k to any one of your family members and count the days till that relationship blows up. Borrow 10 k from anyone of them and same will happen
0 · Reply
Bezhadimmu
Bezhadimmu Oct. 25 at 2:42 AM
$SRPT go jays! Fuck the dodgers! Their team a bunch of over paid zero chemistry bums! Jays are organically built!
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 2:23 AM
Enter: $SRPT NOV 14 2025 $24 CALLS Buy in Price: $1.60 - $2.85 Take Profit: $3.68 Stop Bleeding: $1.41 ROI Potential: 130% https://moneygroup.us/
0 · Reply
conloco
conloco Oct. 25 at 1:51 AM
$SRPT Can’t wait for earnings for Doug to preach what’s been going behind the scenes. All signs point to a great quarter. The weird timing of events and possible buyout talks have surely caused a long overdue PR. Maybe it’s the best course and all of it will make sense in the coming weeks. Nonetheless, not trading this. Just sitting on my position and excited for what’s to come
0 · Reply
Bezhadimmu
Bezhadimmu Oct. 25 at 1:24 AM
$SRPT we have no proof of buyout but can you please provide proof there will not be a buyout. Thank you. Waiting.
3 · Reply
Retter7
Retter7 Oct. 25 at 1:22 AM
$SRPT Elevidys is crushing sales even after the pause. Demand’s real, and the stock looks way undervalued right now. Could be a sleeper pick. 💎📈
0 · Reply
The_Scientist
The_Scientist Oct. 25 at 1:22 AM
$SRPT Book of the Genome — Chapter II: The Long Hold Madness 2:1 Hear ye, ye disciples of the biotech flame, Analysts squawk, but we play the insane game! 2:2 Their “price targets” crawl like worms in clay, FUDsters screech, “It’s down today!” But the genome hums, the prophets say— SRPT will melt their decay! 2:3 And lo! Saint Sarepta, gene-made flame, Burns the shorters, erases shame, Analyst liars, know your blame— Our biotech god shall rename the game! Amen
0 · Reply
Retter7
Retter7 Oct. 25 at 12:48 AM
$SRPT Analysts have issued 12-month price targets, with an average of $24.35 and estimates reaching as high as $80. The outlook suggests that meaningful developments may be unfolding behind the scenes, and I intend to remain invested to capture the potential upside. As I’ve stated before, my position remains firm I won’t be selling until this stock reaches triple digits.
0 · Reply
Thaigrlsrk
Thaigrlsrk Oct. 25 at 12:34 AM
$SRPT Do not forget Ian Guided they could continue to fund ALL 4 ARWR drugs development with just revenues from PMO's and Elevidys Ambulant kids only.
0 · Reply
biomaster22
biomaster22 Oct. 25 at 12:18 AM
$SRPT market up huge srpt up 1.00 total bs Nobody believes in Doug Buyout that’s a pipe dream !
1 · Reply
Vision2025
Vision2025 Oct. 24 at 11:48 PM
$SRPT 60+
0 · Reply
Find_the_Cure
Find_the_Cure Oct. 24 at 11:42 PM
$SRPT let’s do this!!!
0 · Reply
AnydayAnytime
AnydayAnytime Oct. 24 at 11:15 PM
2 · Reply
Thaigrlsrk
Thaigrlsrk Oct. 24 at 10:37 PM
$SRPT Nut job wants Sarepta sold to Roche for 10, Sarepta will not sell less then 20 EOS. Why would they? because the SP is down where it shouldn't be ? If Sarepta was 10 now they might sell for 20 but i doubt it. This is a company and a management that just made the deal of a lifetime with ARWR, and has the revenue (even without the non ambs)to build a powerhouse Pharma and that is what DI and Ian are about.
1 · Reply
Fred_Sigma_Invest
Fred_Sigma_Invest Oct. 24 at 10:30 PM
$SRPT Good Luck, Bulls!
0 · Reply
LearnedPatience
LearnedPatience Oct. 24 at 9:46 PM
$SRPT pay us! $150+
0 · Reply
Initiator1
Initiator1 Oct. 24 at 9:30 PM
$SRPT Several actions taken by the company in last 6 months are clear buyout signals. However, I think there’s a deadlock in negotiations - perhaps the differential between the buyout offer and asking price is huge. For context, just about a years back, the company won’t sell for less than $300/share (c. $30 billion valuation). Here’s what I think is happening: Roche or some other big pharma want the company for $7-8 bn. $SRPT management doesn’t want to sell for less than $15 bn. Anyway, we can all wish the buyout is announced soon and at $100+ / share.
2 · Reply